Pfizer says pill to treat COVID-19 could be authorized by end of year or early 2022: 'It is a game changer'

Pfizer has announced that new data confirm its antiviral pill is effective at reducing the risk of hospitalization or death from COVID-19.
The company said Tuesday final trial results confirmed the antiviral pill reduced the risk of hospitalization or death for high-risk COVID-19 patients by 89 percent when given within three days of symptoms developing. This confirmed earlier data from a clinical trial. Pfizer executive Annaliesa Anderson previously told The New York Times that those results were "really beyond our wildest dreams."
Additionally, the company said Tuesday that the pill worked against the new Omicron variant of COVID-19 in lab studies, according to The New York Times.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"This underscores the treatment candidate's potential to save the lives of patients around the world," Pfizer CEO Albert Bourla said.
Pfizer said this new data has been shared with the FDA as part of its Emergency Use Authorization submission, and Bourla told ABC News that the pill could be authorized in the United States by the end of the year or early 2022. "It is a game changer," Bourla also told ABC. "But at the same time, I want to emphasize that no one should use the existence of the pill as an excuse to avoid vaccination."
An FDA advisory panel previously recommended emergency authorization be granted to a COVID-19 pill from Merck. According to CNN, the FDA hasn't yet set a date for when its advisory committee will consider Pfizer's treatment.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Today's political cartoons - March 9, 2025
Cartoons Sunday's cartoons - proportional protests, shakedown diplomacy, and more
By The Week US Published
-
A wine-themed tour of beautiful Uruguay
The Week Recommends Secret paradise in South America boasts beautiful vineyards
By The Week UK Published
-
Romanian democracy: no place for the 'TikTok messiah' Calin Georgescu
Talking Point State is 'fighting back' against poster boy for right-wing conspiracists
By The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published